|
R-2hg-Based Therapeutic Strategies Targeting Cancers (117-029)
According to the reports of the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program, in 2016 there were an estimated 414,773 people living with leukemia in the United States. Additionally, in 2016, there were an estimated 165,813 people living with brain and other nervous system cancer in the United States. With the...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Rui Su, Jianjun Chen
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Biomedical, Technology Classifications > Life Sciences > Diseases & Disorders > Cancer, Technology Classifications > Life Sciences > Diseases & Disorders > Neurologic, Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Diseases & Disorders
|
|
Method for Treating Acute Myeloid Leukemia with a Mir-22 Nanoparticle (117-006)
Acute Myeloid Leukemia (AML) is one of the most common and fatal forms of hematopoietic malignancies. Despite intensive chemotherapies, the majority of patients with AML fail to survive longer than 5 years. MicroRNA-22 (miR-22) has recently been shown to be an essential anti-tumor gatekeeper in various types of AML. Nanoparticles complexed with either...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Xi Jiang, Jianjun Chen
Keywords(s):
Category(s): Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Biomedical
|
|
Methods for Treating Acute Myeloid Leukemia with Mir-150 Nanoparticles (116-038)
Acute myeloid leukemia (AML) is one of the most common and fatal forms of hematopoietic malignancies. With standard chemotherapies, only 30-40% AML patients under 60 and 5-15% of AML patients older than 60 survive more than 5 years. One avenue for new treatment is through treatment with microRNAs (miRNA); however, successful clinical implementation...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Zejuan Li, Seungpyo Hong, Xi Jiang, Jianjun Chen
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Diseases & Disorders > Cancer, Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Diseases & Disorders, Technology Classifications > Life Sciences > Biomedical, Technology Classifications > Life Sciences > Therapeutics
|